tert-Butyl 2-(3-acetylamino-2-oxo-1,2-dihydro-1-pyridyl)acetate

by Peter C. Healy, Ian D. Jenkins, Wendy A. Loughlin, N. David Karis
Published 2008-12-01

Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design.

by Ola Fjellström, Sibel Akkaya, Hans-Georg Beisel, Per-Olof Eriksson, Karl Erixon, David Gustafsson, Ulrik Jurva, Daiwu Kang, David Karis, Wolfgang Knecht, Viveca Nerme, Ingemar Nilsson, Thomas Olsson, Alma Redzic, Robert Roth, Jenny Sandmark, Anna Tigerström, Linda Öster
Published 2015-01-01